XSXiao‐Rui Shi

Xiao‐Rui Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiao‐Rui Shi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Astrocyte‐Associated ABCA1/APOE Responses Accompany Hippocampal Lipid Remodeling and Ectopic Neuronal Accumulation During Epileptogenesis

    by Lu Chen, Xiao‐Rui Shi, Jia‐Yi Chen, Ying‐Ting Wang, Le Du, Yang Ni, Jun‐Min Chen, An‐Chen Guo, Qian Wu, Jian‐Ping Wu, et al.

    Temporal lobe epilepsy (TLE) is characterized by progressive hippocampal remodeling, including reactive astrogliosis and aberrant neuronal positioning. Although lipid disturbances are implicated in epileptogenesis, how astrocyte‐associated lipid responses relate to hippocampal remodeling remains poorly understood. Here, human TLE and kainic acid (KA)‐treated mouse transcriptomic datasets identified ATP‐binding cassette transporter A1 (ABCA1)/Abca1 as a nominal astrocyte‐associated candidate, while KA‐ and pilocarpine‐induced status epilepticus (SE) elicited astrocyte‐associated ABCA1/apolipoprotein E (APOE) responses. Ectopic granule cells and immature neurons accumulated in the hilus and were spatially associated with ABCA1‐positive cells, including astrocytic profiles; perilipin 2 (PLIN2)‐positive puncta were nearby. Pretreatment with the retinoid X receptor (RXR) agonist bexarotene increased hippocampal ABCA1 expression, delayed severe KA‐induced behavioral seizure onset, and was associated with fewer chronic spontaneous seizures and reduced ectopic neuronal accumulation. Post‐SE bexarotene administration was associated with lower seizure frequency, ectopic neuronal accumulation, and astrocytic marker‐positive cell densities. Multi‐omic profiling identified bexarotene‐associated metabolic and lipidomic changes; transmission electron microscopy (TEM) showed a smaller mean hilar neuronal lipid‐droplet area per image, and protein analyses identified early changes in p38 and extracellular signal‐regulated kinase 1/2 (Erk1/2) phosphorylation. Together, these findings warrant further investigation of astrocyte‐associated lipid pathways as potential therapeutic targets in epilepsy‐associated hippocampal remodeling.

  • Frequent involvement of cingulate and insulo‐opercular regions in sleep‐related hypermotor epilepsy: A multimodal presurgical study

    by Fei Zhu, Xiao‐Rui Shi, Shi‐Wen Weng, Luisa Delazer, Nicholas Fearns, Thaera Arafat, Rui‐Juan Lv, Wen‐Han Hu, Chao Zhang, Matthias Koepp, et al.

    Objective: Sleep‐related hypermotor epilepsy (SHE) is classically considered a frontal lobe epilepsy; however, accumulating evidence suggests that hypermotor seizures may arise from multiple frontal and extrafrontal regions. We characterized the anatomical distribution of best available localizations in patients with SHE using multimodal presurgical data. Methods: We retrospectively analyzed 17 patients with clinically diagnosed SHE who underwent comprehensive evaluation, including long‐term video‐electroencephalographic (EEG) monitoring, 3‐T high‐resolution magnetic resonance imaging (MRI), 18F‐fluorodeoxyglucose positron emission tomography, and, where indicated, magnetoencephalography, stereo‐EEG (SEEG), and surgical assessment. Best available anatomical localizations were assigned using a hierarchical multimodal framework incorporating surgical, SEEG, and concordant noninvasive findings. Their anatomical distribution was subsequently assessed at the cohort level. Results: Sixteen patients (94.1%) had an assigned best available localization. Cingulate or insulo‐opercular regions were involved in 11 of 16 patients (68.8%), whereas the remaining cases were localized to other frontal regions. In a sensitivity analysis restricted to 10 patients with SEEG‐defined and/or surgically supported localizations, six involved cingulate or insulo‐opercular regions. All patients were MRI‐negative. In contrast, MRI–positron emission tomography fusion provided regionally informative anatomical findings in 16 of 17 cases and contributed to multimodal localization. Interictal epileptiform discharges were identified in 15 patients, whereas regionally informative ictal scalp EEG patterns were observed in eight; ictal interpretation was frequently limited by rapid propagation, movement‐related artifacts, and delayed EEG onset. Focal cortical dysplasia‐related histopathological findings were identified in five of seven resected specimens, whereas interpretation in two was limited by prior thermocoagulation. Significance: These descriptive findings indicate that cingulate and insulo‐opercular regions were frequently represented among the identified localizations in this presurgical cohort. Multimodal evaluation integrating electroclinical, imaging, and invasive findings may support presurgical localization in MRI‐negative SHE.

  • Open Access

    Inhibiting acid‐sensing ion channel exerts neuroprotective effects in experimental epilepsy via suppressing ferroptosis

    by Xiaorui Shi, Ru Liu, Yingting Wang, Tingting Yu, Kai Zhang, Chao Zhang, Yuyu Gu, Limin Zhang, Jianping Wu, Qun Wang, et al.

    Background: Epilepsy is a chronic neurological disease characterized by repeated and unprovoked epileptic seizures. Developing disease‐modifying therapies (DMTs) has become important in epilepsy studies. Notably, focusing on iron metabolism and ferroptosis might be a strategy of DMTs for epilepsy. Blocking the acid‐sensing ion channel 1a (ASIC1a) has been reported to protect the brain from ischemic injury by reducing the toxicity of [Ca 2+ ] i . However, whether inhibiting ASIC1a could exert neuroprotective effects and become a novel target for DMTs, such as rescuing the ferroptosis following epilepsy, remains unknown. Methods: In our study, we explored the changes in ferroptosis‐related indices, including glutathione peroxidase (GPx) enzyme activity and levels of glutathione (GSH), iron accumulation, lipid degradation products‐malonaldehyde (MDA) and 4‐hydroxynonenal (4‐HNE) by collecting peripheral blood samples from adult patients with epilepsy. Meanwhile, we observed alterations in ASIC1a protein expression and mitochondrial microstructure in the epileptogenic foci of patients with drug‐resistant epilepsy. Next, we accessed the expression and function changes of ASIC1a and measured the ferroptosis‐related indices in the in vitro 0‐Mg 2+ model of epilepsy with primary cultured neurons. Subsequently, we examined whether blocking ASIC1a could play a neuroprotective role by inhibiting ferroptosis in epileptic neurons. Results: Our study first reported significant changes in ferroptosis‐related indices, including reduced GPx enzyme activity, decreased levels of GSH, iron accumulation, elevated MDA and 4‐HNE, and representative mitochondrial crinkling in adult patients with epilepsy, especially in epileptogenic foci. Furthermore, we found that inhibiting ASIC1a could produce an inhibitory effect similar to ferroptosis inhibitor Fer‐1, alleviate oxidative stress response, and decrease [Ca 2+ ] i overload by inhibiting the overexpressed ASIC1a in the in vitro epilepsy model induced by 0‐Mg 2+ . Conclusion: Inhibiting ASIC1a has potent neuroprotective effects via alleviating [Ca 2+ ] i overload and regulating ferroptosis on the models of epilepsy and may act as a promising intervention in DMTs.